Viscofan SA (Viscofan) is a producer of food casings, primarily serving the meat industry. It specializes in manufacturing, producing, and distributing casings made from collagen, cellulose, fibrous materials, and plastics. Viscofan's products are used in sausage production and other processed meat applications. The company develops functional solutions and edible vegetable casings.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Viscofan is actively engaged in a range of R&D initiatives focused on collagen and gelatin-based projects for tendon and cartilage regeneration, advanced therapy medicinal products, cardiac regeneration, and 3D solutions for Organ on a Chip. The company emphasizes continuous innovation in technology and product development to maintain its leadership in the casing industry. Viscofan is committed to developing new products, enhancing sustainability, improving efficiency, and leveraging digital transformation to drive innovation across all cases of families and their applications. The corporate R&D center in Spain is responsible for coordinating, directing, and supporting the specific R&D activities of each production plant. It manages the coordination of multidisciplinary work teams and aims to share best practices, technological knowledge, and ideas among different production centers. In FY2025, the company incurred an expense of EUR4.1 million on its R&D activities, which grew 5.1%YoY and stood at 0.4% of the company’s total revenue.